Selected Publications

Shah M, Mamtani R, Marmarelis ME, Hennessy S: Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90 Clin Lung Cancer 24 (3): 2023.

Vader DT, Mamtani R, Li Y, Griffith SD, Calip GS, Hubbard RA.: Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation Epidemiology : doi: 10.1097/EDE.0000000000001618,2023.

Mamtani R, Zhang H, Parikh RB, Patel K, Li H, Imai K, Hubbard RA: Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer JAMA Netw Open 6 (4): 2023.

Brown TJ, Mamtani R, Gimotty PA, Karasic TB, Yang YX: Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis J Cancer Res Clin Oncol 149 (6): 2023.

Parikh RB, Hubbard RA, Wang E, Royce TJ, Cohen AB, Clark AS, Mamtani R: Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval JAMA Oncol : doi: 10.1001/jamaoncol.2022.7770,2023.

Herrera CD, Guerra CE, Narayan V, Guzzo TJ, Mamtani R, Lee DJ, Tasian GE, Talwar R: Financial toxicity in prostate cancer survivors: A national cross-sectional assessment of subjective financial burden Urol Oncol : 2023.

Voruganti T, Soulos PR, Mamtani R, Presley CJ, Gross CP: Association Between Age and Survival Trends in Advanced Non-Small Cell Lung Cancer After Adoption of Immunotherapy JAMA Oncol : 2023.

Roberson DS, Xia L, Lee DJ, Pierorazio PM, Malkowicz SB, Mamtani R, Guzzo TJ, Bivalacqua TJ.: Comparison of the 'iROC' trial participants to patients with bladder cancer in the United States undergoing radical cystectomy BJU Int : DOI: 10.1111/bju.15954,2022.

Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA.: NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022 J Natl Compr Canc Netw 23 (8): 2022.

Gotschall JW, Major CK, Jacobs LA, Blauch A, Pucci D, Palmer SC, Mamtani R: Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study BJUI Compass : doi: 10.1002/bco2.204,2022.

Academic Contact Information

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-308
3400 Civic Center Blvd
Philadelphia, PA 19147
Phone: 215-662-7606
Patient appointments: 800-789-7366